Compare Organon Pharma Indonesia Tbk. (SCPI) vs Soho Global Health Tbk (SOHO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Soho Global Health Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Soho Global Health Tbk trades at Rp1,605 (market cap 20.81T, 177.2K 24h volume). The key difference: Soho Global Health Tbk is far larger — about 199.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SOHO | |
|---|---|---|
Market Cap | 104.4B | 20.81T |
Volume | — | 177.2K |
Lot | — | 1.77K |
Turnover | — | 282.73M |
Average Price | — | 1,595.54 |
Value | — | 282.73M |
Indicative Equilibrium Price | — | 1,605 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Soho Global Health Tbk
PT Soho Global Health Tbk (the Company), was established in Jakarta based on Notarial Deed No. 116 of Elisa Pondaag, S.H., dated August 27, 1956 under the name of PT Parit Padang. The Company started its commercial activitiesin 1956.
Read more on SOHO →
